Yiqi Fu

1.0k total citations
25 papers, 783 citations indexed

About

Yiqi Fu is a scholar working on Molecular Medicine, Epidemiology and Infectious Diseases. According to data from OpenAlex, Yiqi Fu has authored 25 papers receiving a total of 783 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Medicine, 11 papers in Epidemiology and 8 papers in Infectious Diseases. Recurrent topics in Yiqi Fu's work include Antibiotic Resistance in Bacteria (12 papers), Vibrio bacteria research studies (4 papers) and Antifungal resistance and susceptibility (4 papers). Yiqi Fu is often cited by papers focused on Antibiotic Resistance in Bacteria (12 papers), Vibrio bacteria research studies (4 papers) and Antifungal resistance and susceptibility (4 papers). Yiqi Fu collaborates with scholars based in China, United States and Japan. Yiqi Fu's co-authors include Jianying Zhou, Hua Zhou, Yunsong Yu, Lanjuan Li, Qing Yang, Min Xu, Haishen Kong, Yake Yao, Yu Chen and Zeqing Wei and has published in prestigious journals such as PLoS ONE, Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Yiqi Fu

23 papers receiving 772 citations

Peers

Yiqi Fu

EPIDE

ENDOC

Rebekah M. Martin United States

Tomoo Saga Japan

María Isabel Morosini Spain

Jean‐Luc Donay France

Doroti de Oliveira Garcia Brazil

Mirjana Mirčeta Australia

Ayşegül Çopur Çiçek Türkiye

Fatima M’Zali France

Nigel F. Pratt Australia

Zerrin Aktaş Türkiye

Rebekah M. Martin United States

Yiqi Fu

642 ×1.4

222 ×0.9

EPIDE

267 ×1.3

250 ×1.2

ENDOC

126 ×0.7

Citations per year, relative to Yiqi Fu Yiqi Fu (= 1×) peers Rebekah M. Martin

Countries citing papers authored by Yiqi Fu

Since Specialization

Citations

This map shows the geographic impact of Yiqi Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yiqi Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yiqi Fu more than expected).

Fields of papers citing papers by Yiqi Fu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yiqi Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yiqi Fu. The network helps show where Yiqi Fu may publish in the future.

Co-authorship network of co-authors of Yiqi Fu

This figure shows the co-authorship network connecting the top 25 collaborators of Yiqi Fu. A scholar is included among the top collaborators of Yiqi Fu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yiqi Fu. Yiqi Fu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fu, Yiqi, et al.. (2025). Psittacosis pneumonia with the reversed halo sign: a case report and literature review. BMC Infectious Diseases. 25(1). 717–717. 1 indexed citations

Xu, Min, Yuchao Zhang, Yajie Fu, et al.. (2025). Evaluation of EUCAST rapid antimicrobial susceptibility testing (RAST) for carbapenemase-producing Klebsiella pneumoniae with focus on KPC variants. European Journal of Clinical Microbiology & Infectious Diseases. 44(12). 3079–3086.

Fu, Yiqi, et al.. (2022). Nosocomial Infections in Nonsurgical Patients Undergoing Extracorporeal Membrane Oxygenation: A Retrospective Analysis in a Chinese Hospital. Infection and Drug Resistance. Volume 15. 4117–4126. 8 indexed citations

Xu, Fei, Zhu Zeng, Bing Yan, et al.. (2021). Safety and efficacy of anti-PD-1 inhibitors in Chinese patients with advanced lung cancer and hepatitis B virus infection: a retrospective single-center study. Translational Lung Cancer Research. 10(4). 1819–1828. 8 indexed citations

Xu, Li, Qing Yang, Hao Xu, et al.. (2021). Emergence of transferable ceftazidime–avibactam resistance in KPC-producing Klebsiella pneumoniae due to a novel CMY AmpC β-lactamase in China. Clinical Microbiology and Infection. 28(1). 136.e1–136.e6. 18 indexed citations

Fu, Yiqi, Min Xu, Yanchao Liu, Ang Li, & Jianying Zhou. (2019). Virulence and genomic features of a blaCTX-M-3 and blaCTX-M-14 coharboring hypermucoviscous Klebsiella pneumoniae of serotype K2 and ST65. Infection and Drug Resistance. Volume 12. 145–159. 17 indexed citations

Xu, Min, Yiqi Fu, Hao Xu, et al.. (2019). High prevalence of KPC-2-producing hypervirulent Klebsiella pneumoniae causing meningitis in Eastern China. Infection and Drug Resistance. Volume 12. 641–653. 79 indexed citations

Fu, Yiqi, Min Xu, Hua Zhou, et al.. (2019). Microbiological and clinical characteristics of cryptococcemia: a retrospective analysis of 85 cases in a Chinese hospital. Medical Mycology. 58(4). 478–484. 9 indexed citations

Yao, Yake, Hua Zhou, Yihong Shen, et al.. (2018). Evaluation of a quantitative serum Aspergillus fumigatus‐specific IgM assay for diagnosis of chronic pulmonary aspergillosis. The Clinical Respiratory Journal. 12(11). 2566–2572. 10 indexed citations

10.

Xu, Min, Ang Li, Haishen Kong, et al.. (2018). Endogenous endophthalmitis caused by a multidrug-resistant hypervirulent Klebsiella pneumoniae strain belonging to a novel single locus variant of ST23: first case report in China. BMC Infectious Diseases. 18(1). 669–669. 32 indexed citations

11.

Xu, Min, Yiqi Fu, Haishen Kong, et al.. (2018). Bloodstream infections caused by Klebsiella pneumoniae: prevalence of blaKPC, virulence factors and their impacts on clinical outcome. BMC Infectious Diseases. 18(1). 358–358. 49 indexed citations

12.

Huang, Guangwei, Yiqi Fu, Han Xue, & Huibin Li. (2018). A Century-Long Ex-Post Evaluation of a Countermeasure for a Serious Pollution Problem in Japan. Sustainability. 10(12). 4385–4385. 2 indexed citations

13.

Yao, Yake, Hua Zhou, Yihong Shen, et al.. (2017). Evaluation of a commercial quantitative Aspergillus fumigatus-specific IgM assay for the diagnosis of invasive pulmonary aspergillosis. Medicine. 96(51). e9436–e9436. 4 indexed citations

14.

Pan, Zhijie, Rong Liu, Pei Zhang, et al.. (2016). Combination of Tigecycline and Levofloxacin for Successful Treatment of Nosocomial Pneumonia Caused by New Delhi Metallo-β-Lactamase-1-Producing Raoultella planticola. Microbial Drug Resistance. 23(1). 127–131. 13 indexed citations

15.

Liu, Lilin, Shujuan Ji, Zhi Ruan, et al.. (2015). Dissemination of bla _OXA-23 in Acinetobacter spp. in China: Main Roles of Conjugative Plasmid pAZJ221 and Transposon Tn 2009. Antimicrobial Agents and Chemotherapy. 59(4). 1998–2005. 45 indexed citations

16.

Pan, Zhijie, et al.. (2015). Diagnostic accuracy of a novel lateral-flow device in invasive aspergillosis: a meta-analysis. Journal of Medical Microbiology. 64(7). 702–707. 51 indexed citations

17.

Fu, Yiqi, Hua Zhou, Yan Jiang, et al.. (2014). Characterization of a Novel Plasmid Type and Various Genetic Contexts of blaOXA-58 in Acinetobacter spp. from Multiple Cities in China. PLoS ONE. 9(1). e84680–e84680. 41 indexed citations

18.

Zhou, Zhihui, Xiaoxing Du, Li Wang, et al.. (2011). Clinical Carbapenem-Resistant Acinetobacter baylyi Strain Coharboring bla _SIM-1 and bla _OXA-23 from China. Antimicrobial Agents and Chemotherapy. 55(11). 5347–5349. 29 indexed citations

19.

Xu, Min, Baohong Wang, Yiqi Fu, et al.. (2011). Changes of Fecal Bifidobacterium Species in Adult Patients with Hepatitis B Virus-Induced Chronic Liver Disease. Microbial Ecology. 63(2). 304–313. 90 indexed citations

20.

Fu, Yiqi, Jianying Zhou, Hua Zhou, et al.. (2010). Wide dissemination of OXA-23-producing carbapenem-resistant Acinetobacter baumannii clonal complex 22 in multiple cities of China. Journal of Antimicrobial Chemotherapy. 65(4). 644–650. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact